Papers
10
Total Citations
144
H-Index
6
About
Dr. Incheon Kang is a pioneering surgeon advancing the frontiers of minimally invasive hepatobiliary and pancreatic surgery, with a specialized focus on robotic and single-port techniques. His major contributions center on demonstrating the feasibility and safety of novel robotic platforms, including the da Vinci SP single-port system and the Korean-made Revo-i system, for complex procedures. Notably, Dr. Kang performed the first da Vinci SP single-port cholecystectomy (30 citations) and the first Revo-i pancreaticoduodenectomy for insulinoma (24 citations), showcasing his role as an early adopter of cutting-edge technology. His work on robotic simultaneous resection for colorectal liver metastasis (35 citations) proves the viability of robotic approaches for all liver resection types, while his comparative analysis of SP versus Si cholecystectomy (19 citations) provides critical data on single-port outcomes. With over 140 total citations, Dr. Kang’s research has directly shaped clinical practice, offering patients less invasive options for conditions ranging from gallbladder disease to pancreatic tumors. His technical innovations and comparative studies continue to guide the next generation of robotic surgeons.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5<i>Revo-i</i> assisted robotic central pancreatectomy16 citations · 2020
- 6
- 7
- 8Robotic limited local resection of duodenal juxta‐ampullary neoplasms3 citations · 2020
- 9
- 10